Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 404

    1.

    ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes.

    Tikellis C, Bialkowski K, Pete J, Sheehy K, Su Q, Johnston C, Cooper ME, Thomas MC.

    Diabetes. 2008 Apr;57(4):1018-25. Epub 2008 Jan 30.PMID: 18235039 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.

    Jandeleit-Dahm K, Lassila M, Davis BJ, Candido R, Johnston CI, Allen TJ, Burrell LM, Cooper ME.

    J Hypertens. 2005 Nov;23(11):2071-82.PMID: 16208151 [PubMed - indexed for MEDLINE]Related articles

    3.

    ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

    Soler MJ, Wysocki J, Ye M, Lloveras J, Kanwar Y, Batlle D.

    Kidney Int. 2007 Sep;72(5):614-23. Epub 2007 Jun 20. Erratum in: Kidney Int. 2007 Oct;72(8):1034. PMID: 17579661 [PubMed - indexed for MEDLINE]Related articles

    4.

    Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.

    Davis BJ, Johnston CI, Burrell LM, Burns WC, Kubota E, Cao Z, Cooper ME, Allen TJ.

    Diabetologia. 2003 Jul;46(7):961-71. Epub 2003 Jun 28.PMID: 12838387 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.

    Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ.

    Circulation. 2002 Jul 9;106(2):246-53.PMID: 12105166 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    ACE and ACE2 activity in diabetic mice.

    Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D.

    Diabetes. 2006 Jul;55(7):2132-9.PMID: 16804085 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

    Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME.

    Hypertension. 2003 Mar;41(3):392-7. Epub 2003 Feb 24.PMID: 12623933 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.

    Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC, Backx PH, Penninger JM, Herzenberg AM, Scholey JW.

    Am J Pathol. 2007 Aug;171(2):438-51. Epub 2007 Jun 28.PMID: 17600118 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

    Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D.

    J Am Soc Nephrol. 2006 Nov;17(11):3067-75. Epub 2006 Oct 4.PMID: 17021266 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Angiotensin converting enzyme 2 in the kidney.

    Koitka A, Cooper ME, Thomas MC, Tikellis C.

    Clin Exp Pharmacol Physiol. 2008 Apr;35(4):420-5. Review.PMID: 18307733 [PubMed - indexed for MEDLINE]Related articles

    11.

    Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice.

    Elased KM, Cunha TS, Marcondes FK, Morris M.

    Exp Physiol. 2008 May;93(5):665-75. Epub 2008 Feb 8.PMID: 18263657 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Identification of angiotensin converting enzyme 2 in the rodent retina.

    Tikellis C, Johnston CI, Forbes JM, Burns WC, Thomas MC, Lew RA, Yarski M, Smith AI, Cooper ME.

    Curr Eye Res. 2004 Dec;29(6):419-27.PMID: 15764086 [PubMed - indexed for MEDLINE]Related articles

    13.

    Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.

    Davis BJ, Forbes JM, Thomas MC, Jerums G, Burns WC, Kawachi H, Allen TJ, Cooper ME.

    Diabetologia. 2004 Jan;47(1):89-97. Epub 2003 Nov 29.PMID: 14647892 [PubMed - indexed for MEDLINE]Related articles

    14.

    Renal ACE and ACE2 expression in early diabetic rats.

    Moon JY, Jeong KH, Lee SH, Lee TW, Ihm CG, Lim SJ.

    Nephron Exp Nephrol. 2008;110(1):e8-e16. Epub 2008 Aug 4.PMID: 18679036 [PubMed - indexed for MEDLINE]Related articles

    15.

    Angiotensin-converting enzyme 2 and the kidney.

    Soler MJ, Wysocki J, Batlle D.

    Exp Physiol. 2008 May;93(5):549-56. Epub 2008 Jan 25. Review.PMID: 18223023 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.

    Hamming I, van Goor H, Turner AJ, Rushworth CA, Michaud AA, Corvol P, Navis G.

    Exp Physiol. 2008 May;93(5):631-8. Epub 2008 Jan 11.PMID: 18192334 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    New mass spectrometric assay for angiotensin-converting enzyme 2 activity.

    Elased KM, Cunha TS, Gurley SB, Coffman TM, Morris M.

    Hypertension. 2006 May;47(5):1010-7. Epub 2006 Apr 3.PMID: 16585421 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.

    New JP, Canavan JP, Flyvbjerg A, Hamon G, Bilous RW, Marshall SM.

    Diabetologia. 1996 Feb;39(2):166-71.PMID: 8635668 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.

    Ebrahimian TG, Tamarat R, Clergue M, Duriez M, Levy BI, Silvestre JS.

    Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):65-70. Epub 2004 Nov 4.PMID: 15528473 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.

    Kim JH, Kim JH, Yu YS, Cho CS, Kim KW.

    J Cereb Blood Flow Metab. 2009 Mar;29(3):621-8. Epub 2008 Dec 24.PMID: 19107135 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data